OpenLegislation

Annex I Information requirements for notifications pursuant to Article 17

United Kingdom

Original text. Later amendments are not shown.

A notification pursuant to Article 17 shall contain the following information:

  1. (1)

    evidence that the substance is an existing active substance within the meaning of Article 3(1)(d) of Regulation (EU) No 528/2012;

  2. (2)

    an indication of the product-type(s) concerned by the notification;

  3. (3)

    information on any studies that have been commissioned for the purpose of application for approval or inclusion in F1the Simplified Active Substance list, as well as the expected date of completion;

  4. (4)

    the information referred to in Sections

    1. (a)

      1, 2 and 7.1 to 7.5 of the table in Title 1 of Annex II to Regulation (EU) No 528/2012 for chemical substances;

    2. (b)

      1, 2 and 6.1 to 6.4 of the table in Title 2 of Annex II to Regulation (EU) No 528/2012 for micro-organisms;

  5. (5)

    where the notification has been made in a case referred to in point (a) of Article 15, evidence that the substance was on the market as an active substance of a biocidal product falling under the relevant product-type on the date of notification or publication of the decision or guidance referred to in that point.

Annotations

Textual amendments

F1

Words in Annex 1 para. 3 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 239; 2020 c. 1, Sch. 5 para. 1(1)